Search Results

Filter
  • 1-10 of  12 results for ""Adrenergic alpha-Antagonists""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Use of α1-adrenoceptor antagonists tamsulosin and alfuzosin and the risk of Alzheimer's disease.

  • Authors : Latvala L; School of Pharmacy, University of Eastern Finland, Kuopio, Finland.; Kuopio Research Centre for Geriatric Care, University of Eastern Finland, Kuopio, Finland.

Subjects: Adrenergic alpha-Antagonists*/Adrenergic alpha-Antagonists*/Adrenergic alpha-Antagonists*/adverse effects ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/drug therapy ; Alzheimer Disease*/Alzheimer Disease*/Alzheimer Disease*/epidemiology

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2022 Oct; Vol. 31 (10), pp. 1110-1120. Date of Electronic Publication: 2022 Jul 06.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1099-1557

Record details

×
Academic Journal

Cerebrospinal fluid and plasma disposition of yohimbine and 11-hydroxy-yohimbine in young and older healthy subjects, and Alzheimer's disease patients.

  • Authors : Le Corre PA; Laboratoire de Pharmacie Galénique, Université de Rennes I, France. ; Peskind ER

Subjects: Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*blood ; Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*cerebrospinal fluid ; Aging/Aging/Aging/*blood

  • Source: European journal of clinical pharmacology [Eur J Clin Pharmacol] 1997; Vol. 52 (2), pp. 135-8.Publisher: Springer Country of Publication: Germany NLM ID: 1256165 Publication Model: Print Cited Medium: Print ISSN: 0031-6970 (Print)

Record details

×
Academic Journal

Altered neurotransmission and signal transduction: targets for nicergoline treatment.

  • Authors : Winblad B; Department of Clinical Neuroscience and Family Medicine, Karolinska Institute, Huddinge University Hospital, Sweden.

Subjects: Signal Transduction*; Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*therapeutic use ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy

  • Source: Dementia and geriatric cognitive disorders [Dement Geriatr Cogn Disord] 1997; Vol. 8 Suppl 1, pp. 2-5.Publisher: Karger Country of Publication: Switzerland NLM ID: 9705200 Publication Model: Print Cited Medium: Print ISSN: 1420-8008 (Print)

Record details

×
Academic Journal

Non-adrenoceptor [3H]idazoxan binding sites (I2-imidazoline sites) are increased in postmortem brain from patients with Alzheimer's disease.

  • Authors : Ruiz J; Department of Pharmacology, University of the Basque Country, Leioa, Spain.; Martín I

Subjects: Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*metabolism ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*metabolism ; Dioxanes/Dioxanes/Dioxanes/*metabolism

  • Source: Neuroscience letters [Neurosci Lett] 1993 Sep 17; Vol. 160 (1), pp. 109-12.Publisher: Elsevier Scientific Publishers Ireland Country of Publication: Ireland NLM ID: 7600130 Publication Model: Print Cited Medium: Print ISSN:

Record details

×
Academic Journal

Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression.

  • Authors : Wang LY; VA Northwest Network Mental Illness Research, Education, and Clinical Center (MIRECC), Seattle, WA 98115, USA. ; Shofer JB

Subjects: Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*therapeutic use ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Behavioral Symptoms/Behavioral Symptoms/Behavioral Symptoms/*drug therapy

  • Source: The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry [Am J Geriatr Psychiatry] 2009 Sep; Vol. 17 (9), pp. 744-51.Publisher: Elsevier Country of Publication: England NLM ID: 9309609 Publication Model: Print Cited Medium: Internet ISSN: 1545-7214 (Electronic)

Record details

×
Academic Journal

Nicergoline: parallel evolution of clinical trial methodology and drug development in dementias.

  • Authors : Crook TH; Memory Assessment Clinics Psychologix, Inc. Scottsdale, AZ 85258, USA.

Subjects: Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*therapeutic use ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*drug therapy ; Dementia/Dementia/Dementia/*drug therapy

  • Source: Dementia and geriatric cognitive disorders [Dement Geriatr Cogn Disord] 1997; Vol. 8 Suppl 1, pp. 22-6.Publisher: Karger Country of Publication: Switzerland NLM ID: 9705200 Publication Model: Print Cited Medium: Print ISSN: 1420-8008 (Print)

Record details

×
Academic Journal

Relations between symptomatology and brain function in dementias: double-blind, placebo-controlled, clinical and EEG/ERP mapping studies with nicergoline.

  • Authors : Saletu B; Department of Psychiatry, University of Vienna, Austria.; Anderer P

Subjects: Electroencephalography* ; Evoked Potentials, Auditory*; Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/Adrenergic alpha-Antagonists/*administration & dosage

  • Source: Dementia and geriatric cognitive disorders [Dement Geriatr Cogn Disord] 1997; Vol. 8 Suppl 1, pp. 12-21.Publisher: Karger Country of Publication: Switzerland NLM ID: 9705200 Publication Model: Print Cited Medium: Print ISSN: 1420-8008 (Print)

Record details

×
Academic Journal

Compensatory changes in the noradrenergic nervous system in the locus ceruleus and hippocampus of postmortem subjects with Alzheimer's disease and dementia with Lewy bodies.

  • Authors : Szot P; Northwest Network for Mental Illness Research, Education, and Clinical Center, Veterans Administration Puget Sound Health Care System, Seattle, Washington 98108, USA. ; White SS

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*pathology ; Hippocampus/Hippocampus/Hippocampus/*pathology ; Lewy Body Disease/Lewy Body Disease/Lewy Body Disease/*pathology

  • Source: The Journal of neuroscience : the official journal of the Society for Neuroscience [J Neurosci] 2006 Jan 11; Vol. 26 (2), pp. 467-78.Publisher: Society for Neuroscience Country of Publication: United States NLM ID: 8102140 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Patterns of cerebrospinal fluid catechols support increased central noradrenergic responsiveness in aging and Alzheimer's disease.

  • Authors : Raskind MA; Department of Veterans Affairs Northwest Network Mental Illness Research, Education and Clinical Center (MIRECC), Seattle, Washington, USA.; Peskind ER

Subjects: Aging/Aging/Aging/*physiology ; Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*cerebrospinal fluid ; Catechols/Catechols/Catechols/*cerebrospinal fluid

  • Source: Biological psychiatry [Biol Psychiatry] 1999 Sep 15; Vol. 46 (6), pp. 756-65.Publisher: Elsevier Country of Publication: United States NLM ID: 0213264 Publication Model: Print Cited Medium: Print ISSN: 0006-3223 (Print)

Record details

×
Academic Journal

Dissociation between I2-imidazoline receptors and MAO-B activity in platelets of patients with Alzheimer's type dementia.

  • Authors : Soto J; Department of Pharmacology, University of the Basque Country, Leioa, Bizkaia, Spain.; Ulibarri I

Subjects: Alzheimer Disease/Alzheimer Disease/Alzheimer Disease/*metabolism ; Blood Platelets/Blood Platelets/Blood Platelets/*metabolism ; Monoamine Oxidase/Monoamine Oxidase/Monoamine Oxidase/*metabolism

  • Source: Journal of psychiatric research [J Psychiatr Res] 1999 May-Jun; Vol. 33 (3), pp. 251-7.Publisher: Pergamon Press Country of Publication: England NLM ID: 0376331 Publication Model: Print Cited Medium: Print ISSN: 0022-3956 (Print)

Record details

×
  • 1-10 of  12 results for ""Adrenergic alpha-Antagonists""